The Scientist

» Myriad Genetics Inc.

Most Recent

image: Do Patents Promote or Stall Innovation?

Do Patents Promote or Stall Innovation?

By | June 1, 2016

A petition recently filed with the Supreme Court triggers renewed debate about the role of patents in the diagnostics sector.

3 Comments

image: Myriad, Post Mortem

Myriad, Post Mortem

By | June 1, 2016

David Schwartz of the Illinois Institute of Technology-Chicago, Kent College of Law, discusses the impact of the US Supreme Court unanimously striking down Myriad Genetics' patent of human BRCA genes and tests to detect mutations in them.

0 Comments

image: Myriad Settles Suit

Myriad Settles Suit

By | January 26, 2015

The Utah-based firm has settled its lawsuit claiming patent infringement against Pathway Genomics.

0 Comments

image: Patent Plea Ping Pong

Patent Plea Ping Pong

By | August 21, 2014

A genetic testing firm accused of infringing upon Myriad Genetics’s gene patents fights back in an attempt to wipe other patents out.

1 Comment

image: Another Legal Setback for Myriad

Another Legal Setback for Myriad

By | March 11, 2014

A judge declines Myriad Genetics’s request to block its competitors from selling BRCA tests.  

0 Comments

image: The Scientist on The Pulse #2

The Scientist on The Pulse #2

By | January 8, 2014

Kerry Grens looks back at the biggest science stories in 2013

0 Comments

image: Governing Science

Governing Science

By | December 31, 2013

How the US government impacted life science research in 2013

1 Comment

image: Another Lawsuit over Genetic Tests

Another Lawsuit over Genetic Tests

By | July 11, 2013

Myriad Genetics, the company originally behind tests for the cancer-associated BRCA mutations, is suing two competitors for patent infringement.

0 Comments

image: Court Rules Gene Patents Valid

Court Rules Gene Patents Valid

By | August 17, 2012

Myriad Genetics can hold patents on the BRAC1 and BRAC2 oncogenes, but not on tests comparing DNA sequences.

8 Comments

image: Gene Patents Back in Court

Gene Patents Back in Court

By | June 19, 2012

A public interest legal group has renewed the fight against DNA patenting.

0 Comments

Popular Now

  1. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  2. How Plants Evolved Different Ways to Make Caffeine
  3. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  4. ESP on Trial
    Foundations ESP on Trial

    In the 1930s, parapsychologist Joseph Banks Rhine aimed to use scientific methods to confirm the existence of extrasensory perception, but faced criticisms of dubious analyses and irreproducible results.

RayBiotech